Genovis: scope for increased rate of growth in 2021
Research Note
2021-03-08
07:20
Redeye upgrades estimates and valuation on Genovis slightly following a company visit and a review of the case. Having demonstrated its defensive qualities as far as the corona situation last year, this fine company is well positioned to handle whatever remains in that regard, in our view, and to ultimately capitalise on its excellent long-term prospects.
HÖ
Håkan Östling
Disclosures and disclaimers